Učitavanje...
Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics
Due to their mechanism of action, the new oral anticoagulants are named direct oral anticoagulants (DOACs). Dabigatran is a selective, competitive, direct inhibitor of thrombin (Factor IIa) while rivaroxaban, apixaban and edoxaban act by directly inhibiting the activated Factor X (FXa) in a selectiv...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
PAGEPress Publications
2013-12-01
|
| Serija: | Italian Journal of Medicine |
| Teme: | |
| Online pristup: | http://www.italjmed.org/index.php/ijm/article/view/175 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|